BioMarin Pharmaceutical Details Strategy Refresh, Voxzogo Competition and 40% Margin Goal at TD Cowen Confab [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
BioMarin Pharmaceutical (NASDAQ:BMRN) executives used a fireside chat at TD Cowen's 46th Annual Healthcare Conference to outline the company's refreshed strategy, discuss upcoming competitive dynamics for Voxzogo, and frame key growth and margin expectations tied to its core rare disease franchises and recent acquisitions. Strategy refresh emphasizes business development and scaled rare-disease infrastructure Chief Executive Officer Alexander Hardy said that since becoming CEO two years ago, he led a “strategic refresh” that elevated business development (BD) as a more significant contributor to BioMarin's future. He pointed to two transactions completed last year—Inozyme and the pending Amicus acquisition—as evidence of that shift. Hardy said both acquisitions are expected to fit into BioMarin's existing enzyme therapy business, which he described as operating at scale across 80 countries. ? Uber and Joby Aviation Team Up: Game Changer or Hype? 3 Oversold Stocks with Big RSI
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Pharmaceutical (BMRN) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks [Yahoo! Finance]Yahoo! Finance
- How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal [Yahoo! Finance]Yahoo! Finance
- BioMarin discontinues dosing in certain Voxzogo trials after safety concern [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.MarketBeat
BMRN
Earnings
- 2/23/26 - Beat
BMRN
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/19/26 - Form 4
- 3/19/26 - Form 4
- BMRN's page on the SEC website